Elanco Animal Health Incorporated
Jeffrey N Simmons (PRESIDENT, CEO AND DIRECTOR) reports ELAN insider transactions
About this filing
Elanco Animal Health Incorporated (ELAN) filed Form 4 (insider transaction) with the SEC on Oct 6, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- Jeffrey N Simmons · PRESIDENT, CEO AND DIRECTOR, Director
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 2, 2026 | A · grantDeferred Stock UnitsFootnotes F1, F2 | +127.6843 | $22.14 | $2,826.93 | 25,499.2826 | Direct |
Footnotes
- F1 Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
- F2 Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
More ELAN filings
- 4
Filed Oct 20, 2026
- 4
Filed Oct 20, 2026
- 4
Filed Oct 20, 2026
- 4
Filed Oct 19, 2026
- 144
Filed Oct 15, 2026
- 4
Filed Oct 6, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.